NCT06254768Recruiting
Use of Continuous Glucose Monitors in Children and Adolescents With Obesity
Source: ClinicalTrials.gov · Last updated 12 Feb 2024 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
To study if continuous glucose monitors are feasible for use in children and adolescents with obesity.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 27 Feb 2023
- Start date
- 17 Jan 2023
- Primary completion date
- Mar 2024
- Lead sponsor
- University of California, Los Angeles
- Diseases
- Obesity
- NCT number
- NCT06254768
What you commit to
- Study type: Interventional
- Planned participants: 30
- From 17 Jan 2023 to the primary completion date, Mar 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Previous diagnosis of Prader Willi Syndrome or hypothalamic obesity
- Previous or planned bariatric surgery
- Current use of medication that impacts weight
Lab values
- Hemoglobin A1c \>6.5 %
Other
- Intellectual disability
Who the study is looking for
- Age 10-21 years BMI \>95th percentile
Age in the registry: 10 years to 21 years · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Pediatric Endocrinology Division, University of California Coordinator of this site? Confirm its status | Los Angeles | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.